Reemergence of sucrose nephropathy: acute renal failure caused by high-dose intravenous immune globulin therapy.
Sucrose nephropathy was first described more than 50 years ago. The disorder is characterized by acute renal failure caused by the uptake of sucrose by renal proximal tubule cells with subsequent cellular swelling and occlusion of the tubule lumen. Approximately 114 cases of renal failure have been associated with high-dose intravenous immune globulin (IVIG) therapy. Almost all cases were caused by preparations containing large amounts of sucrose. Clinicians should consider using IVIG preparations containing no sucrose in patients who are at high risk for renal failure. Risk factors include older age, baseline renal failure, and volume contraction.
Zhang
R
R
Department of Medicine, Tulane University School of Medicine, New Orleans 70112, USA.
Szerlip
H M
HM
D000208:Acute Disease; D058186:Acute Kidney Injury / Q000139:chemically induced*; D000367:Age Factors; D000368:Aged; D003711:Demyelinating Diseases / Q000628:therapy; D004487:Edema / Q000139:chemically induced; D017583:Hemodiafiltration; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000009:adverse effects*; D007674:Kidney Diseases / Q000139:chemically induced; D007687:Kidney Tubules, Proximal / Q000187:drug effects / Q000378:metabolism; D008297:Male; D009846:Oliguria / Q000652:urine; D009994:Osmolar Concentration; D020127:Recovery of Function; D012307:Risk Factors; D012964:Sodium / Q000652:urine; D013395:Sucrose / Q000009:adverse effects* / Q000493:pharmacokinetics
D016756:Immunoglobulins, Intravenous; D013395:Sucrose; D012964:Sodium